BURLINGAME, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq:PLSE), a medical technology company developing a proprietary therapeutic tissue treatment platform based on Nano-Pulse Stimulation (NPS), will host its third quarter investor conference call on Monday, November 14, 2016, at 4:30 p.m. EST / 1:30 p.m. PST. The company will highlight progress to date on corporate strategies and upcoming milestones, as well as provide an update on financial results for the quarter ended September 30, 2016.
